| tüüp : |
ajaleht |
| interneti link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=3891 |
|
| uurimisrühmad : |
Boston - Massachusetts Eye and Ear Infirmary, Harvard Medical School |
| Autor : |
Robert M.C, Spurr-Michaud S, Frenette M, Young D, Gipson Ilene K, Dohlman Claes H. |
| pealkiri : |
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation. |
| publikatsioon : |
Int J Pharm Compound ;18, 5: 418-426. 2014 |
|
| Tõendite tase : |
|
| füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
|
ingredientide nimekiri
 Infliximab
|
 |
 |
 |
 |
100 mg
Remicade ® |
| naatriumkarboksümetüültselluloos |
50 mg |
| boorhape |
|
| CaCl2 |
|
| MgCl2 |
|
| KCl |
|
| süstevesi |
>> 10 ml |
|
-20°C |
 |
| 45 |
 |
|
|
|
|
|
100 mg
Remicade ® |
| naatriumkarboksümetüültselluloos |
50 mg |
| boorhape |
|
| CaCl2 |
|
| MgCl2 |
|
| KCl |
|
| süstevesi |
>> 10 ml |
|
4°C |
|
| 45 |
|
|
|
|
|
